Pregnancy Preparation & Prenatal Genetic Testing
What Are Preconception & Prenatal Genetic Tests?
Based on cutting-edge technology and extensive experience, we provide accurate and reliable prenatal genetic testing services.
Our experienced specialists and genetic counseling professionals address prospective parents’ questions and provide kind, thorough guidance throughout the entire testing process.
We offer a variety of prenatal genetic testing programs and provide personalized testing tailored to each individual’s circumstances and needs. We also provide clear and accurate explanations of test results and, when necessary, professional genetic counseling to help prospective parents fully understand the results and make informed, reasonable decisions.
The journey toward welcoming a precious new life is filled with excitement and anticipation. As prospective parents prepare for this special time, prenatal genetic testing is an important option that can help assess the baby’s health in advance and prepare for potential risks. SEOUL MIZ PROMISE IVF supports prospective parents in achieving a healthy pregnancy and childbirth.
Take the first step toward a healthy future for your precious baby with SEOUL MIZ PROMISE IVF.
Inspection method
Non-Invasive Prenatal Testing (NIPT) in Early Pregnancy
Non-Invasive Prenatal Testing (NIPT) is a screening test performed from 10 weeks of pregnancy onward that analyzes fetal DNA from the mother’s blood to assess for chromosomal abnormalities. Compared with conventional serum screening tests, NIPT offers significantly higher accuracy and can screen for chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome with a high degree of reliability. It can also determine the baby’s sex. As NIPT is a safe, non-invasive test that poses no direct risk to the mother or fetus, it is increasingly chosen by many prospective parents.
Multiple Marker Screening in the Second Trimester
Multiple Marker Screening is a non-invasive screening test performed between 15 and 20 weeks of pregnancy. It combines a maternal blood test with an ultrasound examination to assess the risk of fetal chromosomal abnormalities and neural tube defects. This includes screening methods such as the Triple Test and Quad Test. Although its accuracy is lower than that of NIPT, it has the advantage of being relatively simple to perform. If the screening results indicate a high-risk finding, additional diagnostic testing may be required for confirmation.
Invasive Prenatal Diagnosis
Invasive prenatal diagnosis involves directly collecting fetal cells through amniocentesis or chorionic villus sampling (CVS) to accurately diagnose chromosomal and genetic abnormalities. Amniocentesis involves collecting amniotic fluid between 15 and 20 weeks of pregnancy and analyzing fetal cells. Chorionic villus sampling (CVS) involves collecting chorionic villi, a part of the placenta, between 10 and 13 weeks of pregnancy for testing. Although invasive testing offers a very high level of accuracy, rare complications such as miscarriage or infection may occur during the procedure. Therefore, the decision should be made carefully after thorough consultation with a specialist. These tests are primarily performed when a non-invasive screening test indicates a high-risk result or when there is an increased risk of a specific genetic disorder.